title: The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: R
authors.initials: R
authors.lastname: Oprisiu
authors.forename: A T
authors.initials: AT
authors.lastname: Albu
authors.forename: M
authors.initials: M
authors.lastname: Dungaciu
authors.forename: N
authors.initials: N
authors.lastname: El Esper
authors.forename: P
authors.initials: P
authors.lastname: Mornière
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D002112:Calcifediol / Q000097:blood; D002114:Calcinosis / Q000517:prevention & control; D002118:Calcium / Q000627:therapeutic use*; D017610:Calcium Compounds; D002214:Capsules; D002318:Cardiovascular Diseases / Q000517:prevention & control; D018592:Cross-Over Studies; D006801:Humans; D006934:Hypercalcemia / Q000517:prevention & control; D006962:Hyperparathyroidism, Secondary / Q000517:prevention & control; D010710:Phosphates / Q000037:antagonists & inhibitors* / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011073:Polyamines / Q000627:therapeutic use*; D006435:Renal Dialysis; D000069603:Sevelamer
chemical_list: D000085:Acetates; D017610:Calcium Compounds; D002214:Capsules; D010710:Phosphates; D011073:Polyamines; D010758:Phosphorus; D000069603:Sevelamer; D002112:Calcifediol; D002118:Calcium; C120662:calcium acetate